Stratos Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.7M | Sell |
84,091
-12,055
| -13% | -$1.69M | 0.13% | 162 |
|
|
2025
Q4 | $11.8M | Sell |
96,146
-2,309
| -2% | -$281K | 0.13% | 157 |
|
|
2025
Q3 | $10.9M | Buy |
98,455
+14,577
| +17% | +$1.66M | 0.13% | 158 |
|
|
2025
Q2 | $9.3M | Buy |
83,878
+4,461
| +6% | +$475K | 0.13% | 168 |
|
|
2025
Q1 | $8.9M | Sell |
79,417
-4,597
| -5% | -$474K | 0.14% | 155 |
|
|
2024
Q4 | $7.76M | Sell |
84,014
-30,504
| -27% | -$2.75M | 0.11% | 185 |
|
|
2024
Q3 | $9.6M | Buy |
114,518
+1,009
| +0.9% | +$77K | 0.14% | 153 |
|
|
2024
Q2 | $7.79M | Buy |
113,509
+3,894
| +4% | +$260K | 0.12% | 166 |
|
|
2024
Q1 | $8.03M | Buy |
109,615
+3,074
| +3% | +$236K | 0.13% | 160 |
|
|
2023
Q4 | $8.63M | Sell |
106,541
-1,003
| -0.9% | -$78.1K | 0.16% | 139 |
|
|
2023
Q3 | $8.06M | Buy |
107,544
+7,920
| +8% | +$609K | 0.17% | 131 |
|
|
2023
Q2 | $7.68M | Buy |
99,624
+8,133
| +9% | +$649K | 0.17% | 133 |
|
|
2023
Q1 | $7.59M | Buy |
91,491
+1,145
| +1% | +$94.8K | 0.2% | 106 |
|
|
2022
Q4 | $7.76M | Sell |
90,346
-2,137
| -2% | -$169K | 0.2% | 107 |
|
|
2022
Q3 | $5.71M | Sell |
92,483
-4,884
| -5% | -$308K | 0.16% | 136 |
|
|
2022
Q2 | $6.02M | Buy |
97,367
+1,887
| +2% | +$117K | 0.15% | 139 |
|
|
2022
Q1 | $5.68M | Buy |
95,480
+3,171
| +3% | +$203K | 0.13% | 169 |
|
|
2021
Q4 | $6.7M | Buy |
92,309
+586
| +0.6% | +$40.4K | 0.15% | 150 |
|
|
2021
Q3 | $6.41M | Sell |
91,723
-3,130
| -3% | -$220K | 0.16% | 136 |
|
|
2021
Q2 | $6.53M | Buy |
94,853
+5,029
| +6% | +$336K | 0.16% | 137 |
|
|
2021
Q1 | $5.8M | Sell |
89,824
-7,182
| -7% | -$463K | 0.16% | 135 |
|
|
2020
Q4 | $5.65M | Buy |
97,006
+3,602
| +4% | +$217K | 0.17% | 137 |
|
|
2020
Q3 | $5.9M | Buy |
93,404
+1,964
| +2% | +$136K | 0.19% | 122 |
|
|
2020
Q2 | $7.04M | Buy |
91,440
+43,371
| +90% | +$3.32M | 0.25% | 90 |
|
|
2020
Q1 | $3.59M | Buy |
48,069
+9,551
| +25% | +$660K | 0.16% | 127 |
|
|
2019
Q4 | $2.5M | Sell |
38,518
-83
| -0.2% | -$5.41K | 0.1% | 213 |
|
|
2019
Q3 | $2.45M | Sell |
38,601
-984
| -2% | -$64.3K | 0.11% | 209 |
|
|
2019
Q2 | $2.67M | Buy |
39,585
+1,229
| +3% | +$80.8K | 0.12% | 186 |
|
|
2019
Q1 | $2.49M | Buy |
38,356
+1,521
| +4% | +$101K | 0.11% | 201 |
|
|
2018
Q4 | $2.3M | Sell |
36,835
-2,103
| -5% | -$147K | 0.12% | 184 |
|
|
2018
Q3 | $3.01M | Buy |
38,938
+946
| +2% | +$71.4K | 0.13% | 159 |
|
|
2018
Q2 | $2.69M | Sell |
37,992
-2,447
| -6% | -$173K | 0.12% | 185 |
|
|
2018
Q1 | $3.05M | Sell |
40,439
-2,906
| -7% | -$231K | 0.13% | 167 |
|
|
2017
Q4 | $3.1M | Sell |
43,345
-2,827
| -6% | -$215K | 0.14% | 152 |
|
|
2017
Q3 | $3.74M | Sell |
46,172
-31,280
| -40% | -$2.39M | 0.18% | 125 |
|
|
2017
Q2 | $5.48M | Sell |
77,452
-1,816
| -2% | -$121K | 0.28% | 77 |
|
|
2017
Q1 | $5.38M | Buy |
79,268
+12,788
| +19% | +$899K | 0.3% | 75 |
|
|
2016
Q4 | $4.76M | Buy |
66,480
+4,096
| +7% | +$304K | 0.3% | 75 |
|
|
2016
Q3 | $4.94M | Buy |
62,384
+4,702
| +8% | +$382K | 0.33% | 64 |
|
|
2016
Q2 | $4.81M | Buy |
57,682
+27,053
| +88% | +$2.4M | 0.36% | 60 |
|
|
2016
Q1 | $2.81M | Buy |
30,629
+4,638
| +18% | +$418K | 0.24% | 80 |
|
|
2015
Q4 | $2.63M | Buy |
25,991
+2,158
| +9% | +$225K | 0.22% | 86 |
|
|
2015
Q3 | $2.34M | Buy |
23,833
+4,678
| +24% | +$520K | 0.29% | 75 |
|
|
2015
Q2 | $2.24M | Sell |
19,155
-525
| -3% | -$57.4K | 0.29% | 73 |
|
|
2015
Q1 | $1.93M | Buy |
19,680
+2,915
| +17% | +$296K | 0.23% | 90 |
|
|
2014
Q4 | $1.58M | Buy |
16,765
+1,091
| +7% | +$113K | 0.28% | 88 |
|
|
2014
Q3 | $1.67M | Buy |
15,674
+263
| +2% | +$25.8K | 0.39% | 63 |
|
|
2014
Q2 | $1.28M | Buy |
+15,411
| New | +$1.2M | 0.43% | 66 |
|
Other funds holding GILD
VCM
VPM
Stratos Wealth Partners's GILD Position: Q1 2026 in Review
Stratos Wealth Partners reduced its Gilead Sciences (GILD) stake by 13% in Q1 2026, selling an estimated $1.69M and leaving 84,091 shares worth $11.7M. The position accounts for 0.13% of the portfolio, ranked #162.
Stratos Wealth Partners first reported a position in GILD in Q2 2014 and has held it in 48 quarters since. The position peaked at $11.8M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Stratos Wealth Partners held 84,091 shares of Gilead Sciences worth $11.7M as of Q1 2026.
- Stratos Wealth Partners sold 12,055 Gilead Sciences shares in Q1 2026, an estimated $1.69M.
- Gilead Sciences made up 0.13% of Stratos Wealth Partners's portfolio in Q1 2026, its #162 holding.
- Stratos Wealth Partners first reported a position in Gilead Sciences in Q2 2014 and has held it in 48 quarters since.
- Stratos Wealth Partners's Gilead Sciences position peaked at $11.8M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.